Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - MedAmicus, Inc. (NasdaqSC:MEDM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Reports
Recent Events
July 30Price hit new 52-week high ($19.55)
Location
15301 Highway 55 West
Plymouth, MN 55447
Phone: (763) 559-2613
Fax: (763) 559-7548
Employees (last reported count): 90
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 20%
·Over the last 6 months:
 · 3 insider sells; 15.0K shares
  (1.8% of insider shares)
·Institutional: 7% (8% of float)
(7 institutions)
·Net Inst. Buying: 158.0K shares (+35.75%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
MedAmicus, Inc. is a medical products company that consists of two distinct business divisions. The Percutaneous Delivery Solutions Division is engaged in the design, development, manufacture and marketing of percutaneous vessel introducers and related vascular delivery products; and the manufacture of medical devices and components for other medical product companies on a contract basis. The Gynecology Division is engaged in the design, development, manufacture and marketing of an incontinence diagnostic pressure measurement system utilizing a proprietary fiber optic transducer, referred to as the LuMax System. In April 2001, the Company sold the assets of its Gynecology business to CooperSurgical, Inc.
More from Market Guide: Expanded Business Description

Financial Summary
MEDM designs, develops, manufactures and markets a pressure measurement system utilizing a proprietary fiber optic transducer for measuring and monitoring physiological pressures in the human body. The Company also manufacture other medical products on a contract basis. For the six months ended 6/30/01, revenues rose 50% to $5.4 million. Net income from continuing operations totalled $2.1 million, up from $760 thousand. Results reflect higher sales of vessel introducers, and income tax benefits.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

James Hartman, 55
Pres, CEO, Chief Financial Officer, Sec., Director
$150K--  
Mark Kraus, 37
VP and Gen. Mang. of the Percutaneous Delivery Solutions Division
114K$14K
Christina Temperante, 49
VP and Gen. Mang. of the Gynecology Division
129K--  
Dennis Madison, 57
VP of Admin. and Regulatory Affairs
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:MEDMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 5-Sep-2000
$3.00 
Recent Price$16.40 
52-Week High
on 30-July-2001
$19.55 
Beta0.52 
Daily Volume (3-month avg)85.8K
Daily Volume (10-day avg)94.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+404.6%
52-Week Change
relative to S&P500
+577.0%
Share-Related Items
Market Capitalization$69.3M
Shares Outstanding4.22M
Float3.40M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$1.86 
Earnings (ttm)$0.49 
Earnings (mrq)$0.36 
Sales (ttm)$2.49 
Cash (mrq)$0.79 
Valuation Ratios
Price/Book (mrq)8.83 
Price/Earnings (ttm)33.54 
Price/Sales (ttm)6.58 
Income Statements
Sales (ttm)$10.9M
EBITDA (ttm)$1.69M
Income available to common (ttm)$2.20M
Profitability
Profit Margin (ttm)20.1%
Operating Margin (ttm)12.5%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)35.80%
Return on Equity (ttm)58.78%
Financial Strength
Current Ratio (mrq)5.56 
Debt/Equity (mrq)0.04 
Total Cash (mrq)$3.35M
Short Interest
As of 8-Aug-2001
Shares Short17.0K
Percent of Float0.5%
Shares Short
(Prior Month)
9,000 
Short Ratio0.13 
Daily Volume133.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.